Ascendis Pharma, a Copenhagen based pharmaceutical company, has attracted a EUR 17.6m series-A financing round. The investment round was co-led by Sofinnova Partners and Gilde Healthcare Partners. Zweite TechnoStart Ventures Fonds GmbH & Co KG also participated in the funding round. The financial injection will be used to strategically broaden the company’s pipeline and to position itself in the space of lifecycle management of high-value and marketed drugs.
Manufacturer of spare parts for vending and catering mahines expected to post revenues of USD 1.2bn in 2021
GP raised EUR 3.1bn for its PE strategies and plans “a major fundraising programme” in 2022 and 2023
New joiners to strengthen London team and Peter Woods is promoted to managing director
New fund will invest tickets of EUR 3m-10m in companies with more than EUR 1m in cashflow